US Patent 10201531 Indazolyl-oxo-isothiazole compounds

edited on 8 Dec, 2023

Edits made to:

Article (+232 characters)

Article

Patent abstract

The present invention provides a compound represented by Formula (I) or a pharmaceutically acceptable salt thereof or a solvate of these. A compound having Nrf2 activation ability is provided by the present invention.

Edits on 26 Apr, 2023

"update citations for inverse infoboxes"

edited on 26 Apr, 2023

Infobox

Patent Citations Received

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Edits on 26 Mar, 2023

"update citations for inverse infoboxes"

edited on 26 Mar, 2023

Infobox

Patent Citations Received

US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Edits on 25 Mar, 2023

"update citations for inverse infoboxes"

edited on 25 Mar, 2023

Infobox

Patent Citations Received

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Edits on 21 Mar, 2023

"Entity importer update"

edited on 21 Mar, 2023

Infobox

Is a

Patent

Patent Applicant

Current Assignee

United States Patent and Trademark Office

Patent Jurisdiction

Patent Number

102015310

Date of Patent

February 12, 2019

Patent Application Number

157512730

Date Filed

August 10, 2016

Patent Citations Received

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Patent Primary Examiner

Valerie Rodriguez-Garcia

Edits on 20 Mar, 2023

"update citations for inverse infoboxes"

edited on 20 Mar, 2023

Infobox

Patent Citations Received

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

Edits on 7 Dec, 2022

"update inverses"

edited on 7 Dec, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Edits on 8 Oct, 2022

"update inverses"

edited on 8 Oct, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

Edits on 26 Sep, 2022

"Entity importer update"

edited on 26 Sep, 2022

Infobox

Is a

Patent

Patent Applicant

Current Assignee

United States Patent and Trademark Office

Patent Jurisdiction

Patent Number

102015310

Date of Patent

February 12, 2019

Patent Application Number

157512730

Date Filed

August 10, 2016

Patent Citations Received

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Patent Primary Examiner

Valerie Rodriguez-Garcia

Edits on 23 Sep, 2022

"update citations for inverse infoboxes"

edited on 23 Sep, 2022

Infobox

Patent Citations Received

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

Edits on 12 Feb, 2022

"update inverses"

edited on 12 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 11034705 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

Edits on 9 Feb, 2022

"update inverses"

edited on 9 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

US Patent 10894797 Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

Edits on 24 Jan, 2022

"Created via: Entity Importer"